A PILOT STUDY TO OBTAIN PRELIMINARY INFORMATION REGARDING THE EFFICACY AND SAFETY OF THE COMBINATION OF IMMUNE GLOBULIN AND GANCICLOVIR AS COMPARED TO GANCICLOVIR ALONE IN THE TREATMENT OF SIGHT-THREATENING CMV RETINITIS IN PATIENTS WITH AIDS: